ArticleFrontiers in immunology2021

Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation.

Hiroshi Horiuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.